| scholarly article | Q13442814 |
| P50 | author | Shiri Navon-Venezia | Q75437660 |
| P2093 | author name string | David Schwartz | |
| Inna Chmelnitsky | |||
| Yehuda Carmeli | |||
| Mitchell J Schwaber | |||
| Azita Leavitt | |||
| P2860 | cites work | Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel | Q33857230 |
| Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. | Q33965292 | ||
| Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. | Q34201311 | ||
| Utility of NCCLS guidelines for identifying extended-spectrum beta-lactamases in non-Escherichia coli and Non-Klebsiella spp. of Enterobacteriaceae | Q35552314 | ||
| Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test. | Q36541997 | ||
| Ability of the VITEK 2 advanced expert system To identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa. | Q39455190 | ||
| Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital | Q39465236 | ||
| Evaluation of four commercially available extended-spectrum beta-lactamase phenotypic confirmation tests | Q41878926 | ||
| Validation of the VITEK2 and the Advance Expert System with a collection of Enterobacteriaceae harboring extended spectrum or inhibitor resistant beta-lactamases. | Q43785356 | ||
| In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). | Q43805033 | ||
| Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests | Q43869460 | ||
| Detection of extended spectrum beta-lactamases in the routine clinical microbiology laboratory | Q44110769 | ||
| Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection | Q44901126 | ||
| Detection and characterization of extended-spectrum beta-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002. | Q45244902 | ||
| Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates. | Q53941913 | ||
| Acceptable performance of VITEK 2 system to detect extended-spectrum beta-lactamases in clinical isolates of Escherichia coli: a comparative study of phenotypic commercial methods and NCCLS guidelines. | Q54489799 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | expert system | Q184609 |
| P304 | page(s) | 241-243 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum beta-lactamase production in Enterobacter spp | |
| P478 | volume | 44 |
| Q42799124 | Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures |
| Q40050219 | Distribution of blaTEM, blaSHV, and blaCTX-M genes among ESBL-producing P. aeruginosa isolated from Qazvin and Tehran hospitals, Iran |
| Q83242570 | Dominance of CTX-M group 1 beta-lactamase enzymes in ESBL producing E. coli from outpatient urines in neighboring regions of Austria and Italy |
| Q51700680 | Evaluation of detection of extended-spectrum beta-lactamases among Escherichia coli and Klebsiella spp. isolates by VITEK 2 AST-N029 compared to the agar dilution and disk diffusion methods. |
| Q38475591 | Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates |
| Q35090146 | Expert systems in clinical microbiology |
| Q43248345 | Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium |
| Q51008923 | Impact of adopting minimum inhibitory concentration as the determinant of susceptibility to cephalosporins and carbapenems in multi-drug resistant Enterobacteriaceae. |
| Q35913952 | Metallo-beta-lactamase or extended-spectrum beta-lactamase: a wolf in sheep's clothing |
Search more.